In the last trading session, 1.07 million Beam Therapeutics Inc (NASDAQ:BEAM) shares changed hands as the company’s beta touched 2.10. With the company’s per share price at $17.66 changed hands at -$0.23 or -1.31% during last session, the market valuation stood at $1.78B. BEAM’s last price was a discount, traded about -99.6% off its 52-week high of $35.25. The share price had its 52-week low at $13.52, which suggests the last value was 23.44% up since then.
Analysts gave the Beam Therapeutics Inc (BEAM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.39. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended BEAM as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Beam Therapeutics Inc (NASDAQ:BEAM) trade information
Instantly BEAM was in red as seen at the end of in last trading. With action -3.21%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -28.81%, with the 5-day performance at -3.21% in the red. However, in the 30-day time frame, Beam Therapeutics Inc (NASDAQ:BEAM) is 3.85% up.
The consensus price target for the stock as assigned by Wall Street analysts is 37, meaning bulls need an upside of 52.27% from its current market value. According to analyst projections, BEAM’s forecast low is 25 with 55 as the target high. To hit the forecast high, the stock’s price needs a -211.44% plunge from its current level, while the stock would need to soar -41.56% for it to hit the projected low.
Beam Therapeutics Inc (BEAM) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -20.88%. The 2025 estimates are for Beam Therapeutics Inc earnings to decrease by -1.28%, but the outlook for the next 5-year period is at -1.72% per year.
Beam Therapeutics Inc (NASDAQ:BEAM)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.598% or 7.9 million shares worth $185.11 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were ARK ETF Trust-ARK Innovation ETF and iShares Trust-iShares Russell 2000 ETF. With 5.7 shares estimated at $100.65 million under it, the former controlled 5.67% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.39% of the shares, roughly 2.4 shares worth around $42.44 million.
